Sinovac Biotech Ltd (SVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Sales | 36,388 | 21,225 | 20,018 | 6,566 | 12,400 |
| Cost of Goods | 11,190 | 3,670 | 3,760 | 1,440 | 4,630 |
| Gross Profit | 25,230 | 17,540 | 16,250 | 5,110 | 7,760 |
| Operating Expenses | 8,360 | 5,810 | 6,330 | 4,890 | 5,320 |
| Operating Income | 17,028 | 12,415 | 10,688 | 676 | 3,080 |
| Interest Expense | -20 | 240 | 190 | 120 | -180 |
| Other Income | 1,112 | 55 | 52 | 54 | 220 |
| Pre-tax Income | 18,160 | 12,230 | 10,550 | 610 | 3,480 |
| Income Tax | 4,720 | 3,780 | 2,160 | 480 | -270 |
| Net Income Continuous | 8,900 | 5,225 | 5,809 | 25 | 2,400 |
| Net Income | $8,900 | $5,225 | $5,809 | $25 | $2,400 |
| EPS Basic Total Ops | 0.21 | 0.12 | 0.14 | 0.00 | 0.06 |
| EPS Basic Continuous Ops | 0.21 | 0.12 | 0.14 | 0.00 | 0.06 |
| EPS Diluted Total Ops | 0.21 | 0.12 | 0.14 | 0.00 | 0.06 |
| EPS Diluted Continuous Ops | 0.20 | 0.12 | 0.14 | 0.00 | 0.06 |
| EBITDA(a) | $17,868 | $12,945 | $11,118 | $1,106 | $3,080 |